Additional features
-
Night mode
SOCIETY | 12:21 / 18.09.2024
469
1 min read
Pharmaceutical company fined 68 million UZS for counterfeit Imudon production
A company involved in the production of a counterfeit version of the medicine Imudon has been fined 68 million UZS.
Abbott Products Operations AG filed a complaint with the Ministry of Justice against the manufacturer of the counterfeit version of its drug Imudon.
During an inspection of the enterprise "LLC A," it was discovered that a product under the name Nest Imudon was being produced, which closely resembled the original Imudon drug.
It is noted that the director of "LLC A," S.F., had previously been held administratively liable for the production and sale of a counterfeit version of the drug Magne B6. As a result, "LLC A" was fined 68 million UZS.
Related News
12:05 / 17.09.2024
Khorezm resident arrested for attempting to sell nearly 3 billion UZS worth of illegal medicines
16:54 / 29.08.2024
Price inflation in pharmacies results in 5.4 billion UZS in unjustified earnings
11:13 / 20.08.2024
Tashkent authorities seize over $17,000 in counterfeit bills, several suspects arrested
13:51 / 10.08.2024